Molecular therapeutics of hemophilia A and B.

Gong J, Wang HL, Chang LJ

Open source

DOI
10.1080/17474086.2022.2075339
Published
2022 May
Container
Expert review of hematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17474086.2022.2075339,
  title = {Molecular therapeutics of hemophilia A and B.},
  author = {Gong J and Wang HL and Chang LJ},
  year = {2022},
  journal = {Expert review of hematology},
  doi = {10.1080/17474086.2022.2075339},
  url = {https://doi.org/10.1080/17474086.2022.2075339}
}

RIS

TY  - JOUR
TI  - Molecular therapeutics of hemophilia A and B.
AU  - Gong J
AU  - Wang HL
AU  - Chang LJ
PY  - 2022
JO  - Expert review of hematology
DO  - 10.1080/17474086.2022.2075339
UR  - https://doi.org/10.1080/17474086.2022.2075339
ER  - 

APA

J, G., HL, W., & LJ, C. (2022). Molecular therapeutics of hemophilia A and B.. Expert review of hematology. https://doi.org/10.1080/17474086.2022.2075339

Source records